Internal Medicine · Houston, TX
NPI
1033128665
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
915 Gessner Rd, Suite 785
Houston, TX, 77024
Phone (713) 461-9194
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
1,100 services
Medicare patients, 2024
237
Average age 76
Drug cost, 2024
$871K
2,196 prescriptions
Company payments, 2025
$456
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Akram Shakhashiro was code 99232 (hospital e&m - subsequent), 483 times for 87 patients. In total Akram Shakhashiro billed 1,100 services in 20 codes, and Medicare paid $85K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 483 | 87 | $62.75 | $30K |
| 99214 Office E&M - Established | Office | 202 | 88 | $92.09 | $19K |
| 99213 Office E&M - Established | Office | 128 | 77 | $65.63 | $8,400 |
| 99223 Hospital E&M - Initial | Facility | 90 | 75 | $137.69 | $12K |
| 99222 Hospital E&M - Initial | Facility | 50 | 50 | $105.03 | $5,252 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 46 | 14 | $79.17 | $3,642 |
| 99204 Office E&M - New | Office | 17 | 17 | $129.07 | $2,194 |
| G0008 Administration of influenza virus vaccine | Office | 15 | 15 | $32.75 | $491 |
| 90658 Vaccine Product | Office | 15 | 15 | $21.42 | $321 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 13 | 11 | $42.76 | $556 |
By year: 2022 $171K for 21,192 services; 2023 $135K for 1,798 services; 2024 $85K for 1,100 services.
Medicare prescription drug claims, 2024
In 2024, the drug Akram Shakhashiro prescribed most often to Medicare patients was Cefpodoxime Proxetil, with 87 prescriptions and refills. In total Akram Shakhashiro wrote 2,196 Medicare prescriptions that cost $871K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cefpodoxime Proxetil Generic | 87 | 99 | 33 | $9,446 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 77 | 77 | 34 | $1,459 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 64 | 68 | Under 11 | $259K |
| Cefadroxil Generic | 58 | 59 | 25 | $2,362 |
| Doxycycline Hyclate Generic | 53 | 61 | 30 | $1,298 |
| Amlodipine Besylate Generic | 51 | 147 | 22 | $338 |
| Levothyroxine Sodium Generic | 50 | 148 | 17 | $554 |
| Tramadol Hcl Generic | 43 | 44 | 13 | $164 |
| Ciprofloxacin Hcl Generic | 39 | 39 | 26 | $272 |
| Fluconazole Generic | 36 | 40 | 12 | $1,672 |
| Omeprazole Generic | 34 | 73 | Under 11 | $211 |
| Gabapentin Generic | 33 | 59 | 16 | $281 |
| Lisinopril Generic | 33 | 100 | Under 11 | $116 |
| Pantoprazole Sodium Generic | 31 | 65 | 18 | $212 |
| Atorvastatin Calcium Generic | 31 | 73 | 13 | $156 |
Brand drugs: - claims; generic drugs: 1,819 claims; opioid claims: 50.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Akram Shakhashiro $456 ($456 in general payments such as food, travel and fees) from 7 companies. The largest payer was ViiV Healthcare Company with $164.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.